GlaxoSmithKline announced the closure of one of its series of agreements with Aspen Pharmacare Holdings Limited and certain of its subsidiaries (Aspen), which were the subject of announcements by both companies on 12 September 2016.
GlaxoSmithKline announced the closure of one of its series of agreements with Aspen Pharmacare Holdings Limited and certain of its subsidiaries (Aspen), which were the subject of announcements by both companies on 12 September 2016.